Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|July 16, 2014
Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumoursG Del Conte, C Sessa, R von Moos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancerG Grasselli, L Viganò, G Capri, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Phase IB and pharmacological study of the novel taxane BMS-184476 in combination with doxorubicinC Sessa, A Perotti, E Salvatorelli, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2008
Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumoursS Cresta, C Sessa, C V Catapano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivoA Sparreboom, J Verweij, M E van der Burg, et al.
The British Journal of Surgery|March 14, 2020
Multicentre evaluation of case volume in minimally invasive hepatectomyL Viganò, M Cimino, L Aldrighetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxelC Sessa, D Tosi, L Viganò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complexC Sessa, G Capri, L Gianni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2008
Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancerC Sessa, A Perotti, C Noberasco, et al.
Pageof 7